Evidence map›Paper›PMID 26572585›Full record

ArticleScientific reports2015

Role of Integrin β4 in Lung Endothelial Cell Inflammatory Responses to Mechanical Stress.

Weiguo Chen, Yulia Epshtein, Xiuquin Ni, Randal O Dull, Anne E Cress, Joe G N Garcia, Jeffrey R Jacobson

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Endothelial knockdown of the tumor suppressor,American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  5. Vascular mechanotransduction.Physiological reviews · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Weiguo ChenDivision of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois at Chicago, Chicago, IL.
Yulia EpshteinDivision of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois at Chicago, Chicago, IL.
Xiuquin NiDepartment of Anatomy, Harbin Medical University at Daqing, China.
Randal O DullDepartment of Anesthesiology, University of Illinois at Chicago, Chicago, IL.
Anne E CressDepartment of Medicine, University of Arizona, Tucson, AZ.
Joe G N GarciaDepartment of Medicine, University of Arizona, Tucson, AZ.
Jeffrey R JacobsonDivision of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois at Chicago, Chicago, IL.
University of Illinois Chicago · USUniversity of Arizona · USHarbin Medical University · CN

Funding

Tissue Culture Biomechanical CoreP01HL058064 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAL, RATNESHWAR · 1998 to 2012
$27.8M
Structure-Function Analysis of nmMLCK in EC Barrier ResponsesP01HL126609 · NHLBI · UNIVERSITY OF FLORIDA · PI STEVEN M DUDEK · 2016 to 2026
$24.4M
Integrin Beta 4 in Vascular Inflammatory ResponsesR01HL096887 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JACOBSON, JEFFREY R · 2009 to 2013
$1.9M
NHLBI NIH HHS HL096887NHLBI NIH HHS P01 HL058064NHLBI NIH HHS P01 HL126609NHLBI NIH HHS R01 HL096887
6 · The paper itself

Abstract

Simvastatin, an HMG-CoA reductase inhibitor, has lung vascular-protective effects that are associated with decreased agonist-induced integrin β4 (ITGB4) tyrosine phosphorylation. Accordingly, we hypothesized that endothelial cell (EC) protection by simvastatin is dependent on these effects and sought to further characterize the functional role of ITGB4 as a mediator of EC protection in the setting of excessive mechanical stretch at levels relevant to ventilator-induced lung injury (VILI). Initially, early ITGB4 tyrosine phosphorylation was confirmed in human pulmonary artery EC subjected to excessive cyclic stretch (18% CS). EC overexpression of mutant ITGB4 with specific tyrosines mutated to phenylalanine (Y1440, Y1526 Y1640, or Y1422) resulted in significantly attenuated CS-induced cytokine expression (IL6, IL-8, MCP-1, and RANTES). In addition, EC overexpression of ITGB4 constructs with specific structural deletions also resulted in significantly attenuated CS-induced inflammatory cytokine expression compared to overexpression of wildtype ITGB4. Finally, mice expressing a mutant ITGB4 lacking a cytoplasmic signaling domain were found to have attenuated lung injury after VILI-challenge (VT = 40 ml/kg, 4 h). Our results provide mechanistic insights into the anti-inflammatory properties of statins and may ultimately lead to novel strategies targeted at ITGB4 signaling to treat VILI.

Indexed as

Stress, MechanicalAnimalsBronchoalveolar Lavage FluidCell LineCytokinesDisease Models, AnimalEndothelial CellsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsInflammationIntegrin beta4MiceMice, Inbred C57BLMutagenesis, Site-DirectedPermeabilityPhosphorylationCytokinesHydroxymethylglutaryl-CoA Reductase InhibitorsIntegrin beta4Simvastatin

Identifiers

PMID26572585
PMCPMC4647208
OpenAlexW2413544111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.